Competition Manufacturing Pharmaceutical products 
European Pharmaceutical Review
FEBRUARY 13, 2025
Based on the new cost estimates, pharmaceutical manufacturers in Finland alone will be required to fund 280816 million of these expenses, The directive , enforced on 1 January 2025, imposes an extended manufacturer responsibility on the removal of micro-pollutants from wastewaters.
European Pharmaceutical Review
DECEMBER 4, 2023
To address these issues, companies should adopt more advanced production strategies such as continuous flow chemistry, as they can shorten manufacturing processes, increase productivity and throughput. The result is efficient, cost-effective and high-quality (bio)pharmaceutical production.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
eMediWrite
OCTOBER 3, 2022
Understanding a product’s life cycle can assist a company in determining its position in the market relative to rivals and the success or failure of the product. Pharmaceutical firms must deal with various regulatory, linguistic, and counterfeit control needs as a result of global distribution. Technology transfer.
European Pharmaceutical Review
NOVEMBER 3, 2022
Results from CPhI’s 2022 Pharma Index survey , announced at this year’s CPhI Frankfurt, showed pharma confidence in growth , innovation and manufacturing quality has reached record highs, promising positive prospects for the industry in 2023 and beyond. Competitiveness. Germany (in second place) and the UK achieved double-digit growth.
European Pharmaceutical Review
SEPTEMBER 29, 2022
The US Food and Drug Administration (FDA)’s Center for Drug Evaluation and Research (CDER) through the Office of Pharmaceutical Quality in 2021 embarked on an initiative to develop a framework for establishing a pharmaceutical manufacturing site quality rating system, the Quality management maturity (QMM) programme.
PM360
JANUARY 24, 2025
Applying AI to GVDs Amassing comprehensive productand market-related data, GVDs demonstrate the value of a pharmaceutical product to various stakeholders, including payers, healthcare providers, and regulatory bodies. It leveraged experts input at key points in the process, to assess and validate the work.
Pharmaceutical Representative Training
MARCH 17, 2025
One of the most difficult parts of introducing a pharmaceutical product is the regulatory environment. Early on in the process, interact with consumers and estimate the possible long-term benefits your product may provide using predictive analytics.
Expert insights. Personalized for you.
59 
Let's personalize your content